MD Anderson statement regarding an assessment by the Centers for Medicare and Medicaid Services

For nearly 80 years, The University of Texas MD Anderson Cancer Center has been a global leader in the fight to end cancer. Our patients trust us with their care, and we continually strive to exceed their expectations and to improve outcomes.

As part of an ongoing assessment by the Centers for Medicare and Medicaid Services (CMS) and Texas Department of State Health Services, a follow-up visit of MD Anderson was conducted at the end of August. MD Anderson cooperated fully and responded to the final CMS report with an improvement plan, which was accepted without changes by CMS.

A survey to validate MD Anderson’s approved improvement plan was conducted by CMS during the week of Oct. 28. Several steps remain, but CMS surveyors verbally shared with MD Anderson leadership that the institution has cleared all condition-level findings from the August hospital survey and its deemed status will be reinstated.

It is important to note there have been no changes to MD Anderson’s participation in Medicare and Medicaid programs. Patient coverage remains the same as it was prior to the assessment. 

As an institution focused on learning, we take this feedback seriously, and we welcome the opportunity to further improve our patient care and safety protocols. Through intentional, strategic and patient-focused decisions, we have implemented changes into our clinical practice. MD Anderson constantly strives for the best during regular reviews conducted by more than 70 regulatory, professional and accrediting bodies.

We are proud of MD Anderson’s 21,000 faculty and staff who remain steadfast in our commitment to providing patients and their loved ones the safest and highest-quality cancer care. It is our duty and honor to do so as we work to fulfill our mission to end cancer.